ACRS - Aclaris Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACRS is currently covered by 6 analysts with an average price target of $12.61. This is a potential upside of $10.25 (434.32%) from yesterday's end of day stock price of $2.36.

Aclaris Therapeutics's activity chart (see below) currently has 56 price targets and 65 ratings on display. The stock rating distribution of ACRS is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 27.73% with an average time for these price targets to be met of 169.82 days.

Highest price target for ACRS is $16, Lowest price target is $2, average price target is $9.2.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 20-Oct-2025. First documented stock forecast 02-Nov-2015.

Currently out of the existing stock ratings of ACRS, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$16

$13.48 (534.92%)

15 days ago
(20-Oct-2025)

0/6 (0%)

$13.99 (696.02%)

Buy

5 months 26 days ago
(09-May-2025)

0/7 (0%)

$23.92 (169.89%)

Hold

$2

$-0.52 (-20.63%)

$2

8 months 8 days ago
(27-Feb-2025)

2/4 (50%)

$0.05 (2.56%)

271

Buy

$8

$5.48 (217.46%)

11 months 16 days ago
(19-Nov-2024)

0/3 (0%)

$3.41 (74.29%)

Buy

$7

$4.48 (177.78%)

11 months 16 days ago
(19-Nov-2024)

1/4 (25%)

$2.41 (52.51%)

315

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACRS (Aclaris Therapeutics) average time for price targets to be met?

On average it took 169.82 days on average for the stock forecasts to be realized with a an average price target met ratio 27.73

Which analyst has the current highest performing score on ACRS (Aclaris Therapeutics) with a proven track record?

DAVID STEINBERG

Which analyst has the most public recommendations on ACRS (Aclaris Therapeutics)?

David Steinberg has 2 price targets and 2 ratings on ACRS

Which analyst is the currently most bullish on ACRS (Aclaris Therapeutics)?

Pasha Sarraf with highest potential upside - $23.48

Which analyst is the currently most reserved on ACRS (Aclaris Therapeutics)?

Alex Thompson with lowest potential downside - -$0.52

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?